Sinai Health Receives $1-Million Donation to Revolutionize Cancer Diagnostics with Digital Pathology Integration
Nanostics and OncoHelix Partner to Launch AI-Driven Prostate Cancer Test in the Middle East
QIAGEN Secures European IVDR Certification for QIAstat-Dx Syndromic Testing Systems and Assays
Bayer and AskBio Partner with Belief BioMed to Develop Liver-Targeted Gene Therapies
Breakthrough Stem Cell Transplant Offers Insulin Independence for Type 1 Diabetes Patient
Tagrisso Gains FDA Approval for Treatment of Unresectable Stage III EGFR-Mutated Lung Cancer in the US
Tempus and Takeda Expand Partnership to Enhance Cancer Drug Development with Real-World Data
MedGenome and Twist Bioscience Partner to Launch HOPE for Rare Diseases Programme in India
Bioserve Biotechnologies Unveils PreciOnc: Revolutionizing At-Home Genetic Testing for Cancer Risk
Trinity Biotech Expands Maternal Health Portfolio with Acquisition of Metabolomics Diagnostics
Cepheid and Fleming Initiative Join Forces to Combat Antimicrobial Resistance
Qure.ai, Global Healthcare AI Leader, Raises $65 Million in Series D Funding Led by Lightspeed and 360 ONE Asset
CENTOGENE Unveils Novel Genetic Risk Factor for Parkinson’s Disease in The Lancet Neurology
AmoyDx Pan Lung Cancer PCR Panel Approved as Companion Diagnostic for Repotrectinib in Advanced NSCLC
Lilly's Kisunla™ (donanemab-azbt) Gains Approval in Japan for Early Symptomatic Alzheimer's Disease Treatment
